Free Trial

Charlotte's Web (CWEB) Competitors

Charlotte's Web logo
C$0.18 0.00 (0.00%)
(As of 12:49 PM ET)

CWEB vs. HLS, TGOD, NINE, WMD, SUGR, MDP, VIR, ZOM, IN, and META

Should you be buying Charlotte's Web stock or one of its competitors? The main competitors of Charlotte's Web include HLS Therapeutics (HLS), Green Organic Dutchman (TGOD), Delta 9 Cannabis (NINE), WeedMD (WMD), SugarBud Craft Growers (SUGR), Medexus Pharmaceuticals (MDP), Viridium Pacific Group (VIR), Zomedica Pharmaceuticals Corp. (ZOM.V) (ZOM), InMed Pharmaceuticals (IN), and Meta Growth (META). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Charlotte's Web vs.

Charlotte's Web (TSE:CWEB) and HLS Therapeutics (TSE:HLS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, media sentiment, valuation, community ranking, earnings and analyst recommendations.

3.3% of Charlotte's Web shares are held by institutional investors. Comparatively, 65.2% of HLS Therapeutics shares are held by institutional investors. 11.3% of Charlotte's Web shares are held by insiders. Comparatively, 0.4% of HLS Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

HLS Therapeutics received 34 more outperform votes than Charlotte's Web when rated by MarketBeat users. Likewise, 66.67% of users gave HLS Therapeutics an outperform vote while only 0.00% of users gave Charlotte's Web an outperform vote.

CompanyUnderperformOutperform
Charlotte's WebOutperform Votes
No Votes
Underperform Votes
2
100.00%
HLS TherapeuticsOutperform Votes
34
66.67%
Underperform Votes
17
33.33%

In the previous week, HLS Therapeutics had 4 more articles in the media than Charlotte's Web. MarketBeat recorded 4 mentions for HLS Therapeutics and 0 mentions for Charlotte's Web. Charlotte's Web's average media sentiment score of 0.00 beat HLS Therapeutics' score of -0.41 indicating that Charlotte's Web is being referred to more favorably in the media.

Company Overall Sentiment
Charlotte's Web Neutral
HLS Therapeutics Neutral

HLS Therapeutics has a consensus price target of C$3.63, indicating a potential upside of 8.21%. Given HLS Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe HLS Therapeutics is more favorable than Charlotte's Web.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Charlotte's Web
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
HLS Therapeutics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Charlotte's Web has a beta of 1.91, meaning that its share price is 91% more volatile than the S&P 500. Comparatively, HLS Therapeutics has a beta of 1.07, meaning that its share price is 7% more volatile than the S&P 500.

HLS Therapeutics has a net margin of -40.90% compared to Charlotte's Web's net margin of -81.43%. HLS Therapeutics' return on equity of -24.82% beat Charlotte's Web's return on equity.

Company Net Margins Return on Equity Return on Assets
Charlotte's Web-81.43% -77.80% -17.25%
HLS Therapeutics -40.90%-24.82%-2.89%

HLS Therapeutics has higher revenue and earnings than Charlotte's Web. HLS Therapeutics is trading at a lower price-to-earnings ratio than Charlotte's Web, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Charlotte's WebC$54.55M0.52-C$44.42M-C$0.40-0.45
HLS TherapeuticsC$58.89M1.81-C$24.09M-C$1.01-3.32

Summary

HLS Therapeutics beats Charlotte's Web on 13 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

CWEB vs. The Competition

MetricCharlotte's WebDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$28.35MC$1.15BC$5.09BC$6.19B
Dividend YieldN/A3.13%5.04%5.31%
P/E Ratio-0.45109.9794.6026.60
Price / Sales0.521,897.451,217.521,474.09
Price / Cash8.9010.2639.4982.35
Price / Book0.783.066.953.13
Net Income-C$44.42MC$155.48MC$118.83MC$292.70M
7 Day Performance-5.26%-1.12%-1.52%1.32%
1 Month Performance2.86%-3.84%-3.39%13.16%
1 Year Performance-32.08%90.18%32.17%44.29%

Charlotte's Web Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CWEB
Charlotte's Web
N/AC$0.18
flat
N/A-32.1%C$28.35MC$54.55M-0.45164Gap Down
High Trading Volume
HLS
HLS Therapeutics
1.3206 of 5 stars
C$3.35
+7.0%
C$3.63
+8.2%
-14.9%C$106.50MC$58.89M-3.1091Gap Up
TGOD
Green Organic Dutchman
N/AN/AN/AN/AC$89.95MC$31.37M-0.6541Gap Up
High Trading Volume
NINE
Delta 9 Cannabis
N/AC$1.03
+3.0%
N/A+0.0%C$89.36MC$12.87M19.07940Gap Up
WMD
WeedMD
N/AC$0.28
-1.8%
N/A+0.0%C$67.82MC$27.53M-0.66628Gap Up
SUGR
SugarBud Craft Growers
N/AC$9.25
+2.8%
N/A+8,081.8%C$63.09MC$575.64M10.8444Gap Down
MDP
Medexus Pharmaceuticals
2.8875 of 5 stars
C$2.13
-0.9%
C$5.25
+146.5%
+36.9%C$52.25MC$108.78M43.2098Analyst Upgrade
Analyst Revision
VIR
Viridium Pacific Group
N/AC$0.38
+5.6%
N/A+0.0%C$37.52MC$1.09M-2.97580Positive News
Gap Up
ZOM
Zomedica Pharmaceuticals Corp. (ZOM.V)
N/AC$0.29
-6.6%
N/A+0.0%C$36.73MN/A-2.6150Gap Down
IN
InMed Pharmaceuticals
N/AN/AN/AN/AC$33.73MC$574,677.00-2.7712
META
Meta Growth
N/AC$0.14
flat
N/A+0.0%C$33.14MC$60.96M-0.6686,500Gap Down

Related Companies and Tools


This page (TSE:CWEB) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners